Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as ...

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

Novo Nordisk's recent decline suggests it may be a Buy again, with strong growth prospects in diabetes and obesity treatments ...

Wegovy obesity drug sales more than double but set to slow - Sales of Wegovy, a prescription weight loss injection, surged to ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

It found the Danish pharmaceutical company, Novo Nordisk, "spent at least $25.8 million over the past decade on U.S. medical professionals to promote two of its obesity drugs, Wegovy and Saxenda." ...